Development and evaluation of Nurse Practitioner follow-up in the management of patients with lung cancer.
ISRCTN | ISRCTN64726310 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN64726310 |
Secondary identifying numbers | NCP/J17/18 |
- Submission date
- 23/01/2004
- Registration date
- 23/01/2004
- Last edited
- 22/05/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Jessica Corner
Scientific
Scientific
The Institute of Cancer Research
The Centre for Cancer and Palliative Care Studies
Royal Cancer Hospital
Fulham Road
London
SW3 6JJ
United Kingdom
Phone | +44 (0)20 7352 8171 |
---|
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study objectives | Not provided at time of registration |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cancer (neoplasms): Lung (non-small cell) |
Intervention | 1. Conventional medical follow-up: At the specialist cancer hospital, patients were seen within one month and, if stable, discharged back to their referring cancer unit. At the cancer units, follow-up was 2 - 3 monthly if patients were stable. At all centres, patients who were not considered medically stable were seen on the basis of need. 2. Nurse-led follow-up: Patients allocated to one of two Clinical Nurse Specialists (CNS) who took responsibility for their follow-up care for one year. Patients assessed monthly or on basis of need by telephone or at a nurse-led clinic. Patients could also use a paging system to contact CNS if they had concerns during intervals between assessments. Focus of care was not only disease surveillance but also the physical, psychological and social needs of patients and their families. Emphasis on prompt communication and liaison with primary care teams. Patients attended hospital medical clinics only if their condition indicated this was needed or if patients requested a consultation with a hospital physician. |
Intervention type | Other |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/01/1999 |
Completion date | 01/01/2001 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | 1. Patients with lung cancer having completed initial treatment 2. Not requiring immediate medical intervention or close medical supervision 3. Considered to have a good performance status (World Health Organization [WHO] performance status 0 - 2) 4. Had an expected prognosis of at least 3 months 5. Were not participating in other clinical trials requiring intensive medical investigation or follow-up 6. Understood and read English for informed consent and data collection purposes |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/01/1999 |
Date of final enrolment | 01/01/2001 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
The Institute of Cancer Research
London
SW3 6JJ
United Kingdom
SW3 6JJ
United Kingdom
Sponsor information
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government
Government
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
NHS Cancer National Research and Development Programme (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | Results | 16/11/2002 | Yes | No |